Comments
Lupin has recalled 55,348 bottles of generic amlodipine besylate tablets in the US while Cadila Healthcare recalled 14,808 bottles of generic bromocriptine mesylate 5-mg capsules.
The USFDA has categorised the Lupin recall as Class III, meaning the drug is unlikely to cause any adverse effect on health but violates labelling or manufacturing laws.
The Cadila recall, categorised as Class-II, may cause medically reversible adverse health consequences.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.